The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of panitumumab in KRAS wild-type metastatic adenocarcinoma of the small bowel or ampulla of vater.
 
Pat Gulhati
No Relationships to Disclose
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - Genentech (Inst)
 
Rachna T. Shroff
Stock and Other Ownership Interests - Celgene
Consulting or Advisory Role - Agios; Amgen; Celgene; Clovis Oncology; Codiak Biosciences
Research Funding - Agios; Celgene; Lilly
Travel, Accommodations, Expenses - Amgen; Celgene; Codiak Biosciences
 
Gauri R. Varadhachary
Employment - Fannin Partners (I)
Leadership - Fannin Partners (I); Pulmotect (I)
Stock and Other Ownership Interests - Fannin Partners (I)
Honoraria - Celgene; Merrimack; Momenta Pharmaceuticals; Rexahn Pharmaceuticals
Consulting or Advisory Role - Celgene; Merrimack; Momenta Pharmaceuticals; Rexahn Pharmaceuticals
Research Funding - Merck (Inst)
Patents, Royalties, Other Intellectual Property - Spouse is an inventor of use patents relating to recombinant human lactoferrin. The molecule is no longer in development and patents are being allowed to lapse as payments come due. (I); Spouse is inventor on a pending patent for an ELISA diagnostic platform. Not related to my area of research. (I)
Travel, Accommodations, Expenses - Celgene and Merrimack
 
Milind M. Javle
No Relationships to Disclose
 
Wei Qiao
No Relationships to Disclose
 
Huamin Wang
No Relationships to Disclose
 
Jeffrey Morris
No Relationships to Disclose
 
Robert A. Wolff
No Relationships to Disclose
 
Michael J. Overman
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Merrimack; Roche/Genentech; sirtex Medical
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; MedImmune; Merck; Roche